Insulet (PODD) Convertible Debt (2010 - 2011)

Insulet's (PODD) quarterly Convertible Debt came in at $106.3 million in Q3 2011, up 2.06% quarter-over-quarter from $104.2 million in Q2 2011.

Analysis

Insulet (PODD) Convertible Debt (2010 - 2011) Analysis & Trends

Insulet (PODD) has reported Convertible Debt for 2 consecutive years, with $106.3 million the latest figure, recorded in Q3 2011.

For the quarter ending Q3 2011, Convertible Debt changed N/A year-over-year to $106.3 million; the trailing twelve-month figure through Sep 2011 stood at $106.3 million (changed N/A YoY), and the FY2010 full-year result was $69.4 million, changed N/A from the prior year.
Convertible Debt rose to $106.3 million in Q3 2011 per PODD's latest filing, from $104.2 million in the prior quarter.
Across five years, Convertible Debt topped out at $106.3 million in Q3 2011 and bottomed at $69.4 million in Q4 2010.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	180.76 Bn	175.16 Bn	7.27 Bn
2	Intuitive Surgical	127.77 Bn	122.55 Bn	1.96 Bn
3	Medtronic	117.20 Bn	108.39 Bn	6.34 Bn
4	Stryker	104.01 Bn	100.53 Bn	4.50 Bn
5	Boston Scientific	63.51 Bn	62.97 Bn	3.85 Bn
6	Edwards Lifesciences	49.80 Bn	45.55 Bn	1.35 Bn
7	Alcon	33.03 Bn	31.58 Bn	1.68 Bn
8	Dexcom	32.18 Bn	30.23 Bn	830.00 Mn
9	Steris	20.71 Bn	20.23 Bn	684.20 Mn
10	Insulet	9.35 Bn	8.82 Bn	562.60 Mn

Historic Data

Download Data